Clinical Trials on Escherichia coli Infections in Finland

Total 1283 results

Helsinki University Central Hospital
University of Helsinki

Recruiting

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Cholera | Typhoid Fever | Vaccine-Preventable Diseases

Finland
Turku University Hospital

Suspended

The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30 (OPTICAP>30)

Intra-abdominal Infection | Acute Disease | Appendicitis | Gastrointestinal Disease | Other and Unspecified Acute Appendicitis

Finland
GlaxoSmithKline

Completed

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease (FinIP)

Streptococcus Pneumoniae | Infections, Streptococcal

Finland
Finnish Institute for Health and Welfare
Turku University Hospital; GlaxoSmithKline

Completed

Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10

Pneumococcal Infections

Finland
Jarmo Oksi

Completed

COVID-19: Salvage TOcilizumab as a Rescue Measure (COVIDSTORM)

Covid19

Finland
Arto Palmu
GlaxoSmithKline

Completed

Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

Nasopharyngeal Carriage of Streptococcus Pneumoniae

Finland
Hospital District of Helsinki and Uusimaa

Unknown

The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients. (ASGUT)

Ankylosing Spondylitis

Finland
University of Turku
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company

Completed

EUpertstrain 4 Study of Bordetella Pertussis Isolates

Bordetella Pertussis, Whooping Cough

Finland
GlaxoSmithKline

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Herpes Zoster

Spain, Canada, Belgium, Finland, Korea, Republic of, Panama, Taiwan
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

Tuberculosis

Finland
UMC Utrecht
University of Turku; University of Oxford; University of Edinburgh; Servizo Galego...

Active, not recruiting

RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants

Respiratory Syncytial Virus Infections | RSV Infection | RSV Bronchiolitis

United Kingdom, Netherlands, Finland, Spain
Turku University Hospital

Completed

Relation of Skin Closure Method to Groin Wound Infections After Proximal Femoral Artery Exposure.

Surgical Wound Infection

Finland
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Recruiting

SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

Covid19

Finland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Influenza

Finland
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
Turku University Hospital

Completed

Study of Lyme Neuroborreliosis

Lyme Neuroborreliosis

Finland
Helsinki University Central Hospital

Recruiting

AIR-program and HUS Internet Therapy Compared to Treatment as Usual in Functional Disorders and Post Covid-19 Condition

Functional Disorders | Post Covid-19

Finland
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Finnish Institute for Health and Welfare
RWTH Aachen University; University of Erfurt

Completed

Herd Immunity and Influenza Vaccine Uptake (HIIVU)

Influenza, Human

Finland
Helsinki University Central Hospital

Recruiting

Functional Ability, Symptoms and Quality of Life in Patients With Post Covid-19 Condition (LC-cohort)

Post Covid-19 Condition

Finland
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Recruiting

SOLIDARITY Finland Plus Long-COVID

Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Acute Respiratory Disease

Finland
Pfizer

Completed

A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

MENINGOCOCCAL INFECTION

Finland, Poland
Helsinki University Central Hospital

Completed

Targeting of Immune Response After Pneumococcal Vaccination (PncHR)

Pneumococcal Pneumonia

Finland
Novartis Vaccines

Completed

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

FLU

Finland
University of Helsinki
AbbVie

Unknown

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis (PETSPA)

Ankylosing Spondyloarthritis

Finland
Helsinki University Central Hospital
Finnish Red Cross Blood Service

Active, not recruiting

Convalescent Plasma in the Treatment of Covid-19 (CP_COVID-19)

Covid19

Finland
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Sormland County Council, Sweden

Completed

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Finland, Sweden
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Prophylaxis of Avian Influenza

Finland
Tampere University

Completed

Helicobacter Pylori and Acute Alcohol Induced Pancreatitis

Helicobacter Infections | Pancreatitis, Acute

Finland
Butler Hospital

Completed

Preventing Bacterial and Viral Infections Among Injection Drug Users

HIV | Bacterial Infection

United States
Finnish Institute for Health and Welfare

Completed

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Influenza Caused by the 2009 H1N1 Influenza Virus

Finland
Finnish Institute for Health and Welfare
Norwegian Institute of Public Health; Karolinska Institutet

Active, not recruiting

Tobacco Use and Uptake of COVID-19 Vaccinations

Smoking | COVID-19 | Tobacco Use | Vaccination Refusal

Finland
Helsinki University Central Hospital

Terminated

Treatment of Giardia Lamblia Infections in Children

GIARDIASIS

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Influenza | Orthomyxoviridae Infections | Orthomyxovirus Infections

Finland
TILT Biotherapeutics Ltd.

Recruiting

TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy (TUNIMO)

Solid Tumor

Finland
UKK Institute
University of Eastern Finland; North Karelia Hospital District

Unknown

eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 (MySteps-CoV)

Type2 Diabetes

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of Pandemic Vaccination Campaign

Influenza Caused by the Novel A(H1N1)v Influenza Virus

Finland
University of Helsinki

Completed

Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia (FINLEVO)

Sepsis | Bacteremia | Staphylococcus Aureus | Endocarditis

Finland
Helsinki University Central Hospital

Completed

Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery (PERICLASS)

Peritonitis

Finland
University of Oulu
Oulu University Hospital

Completed

Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization

Chest Pain | Fever of Unknown Origin | Dyspnea | Respiratory Virus Infection

Finland
Kent Hospital, Rhode Island
National Institute of General Medical Sciences (NIGMS)

Active, not recruiting

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care

Latent Tuberculosis

United States
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
Astra USA

Completed

The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment

HIV Infections | Herpes Simplex

United States
Northwell Health
Staten Island University Hospital

Completed

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?

Tuberculosis

United States

Clinical Trials on Escherichia coli Infections in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations